NAD+ Injections: What the Evidence Actually Shows for Energy & Longevity (2026)

NAD+ injections sit at the center of the longevity and energy boom, marketed in IV clinics and home-injection kits as a way to feel younger, think sharper, and slow aging. The science is real but early: NAD+ is a genuinely essential molecule, and you can raise its levels in the body, but the human evidence that doing so produces the benefits people pay for is thin and mixed. This review separates what the molecule actually does from what the marketing promises, grades the evidence honestly, and explains who might reasonably consider it.

What NAD+ Is and Why It Matters

NAD+ stands for nicotinamide adenine dinucleotide. It's a coenzyme found in every living cell. Your body can't run without it.

Think of NAD+ as a shuttle. It carries electrons during the chemical reactions that turn food into energy. Without enough NAD+, your mitochondria — the tiny power plants inside cells — can't make ATP, the fuel that runs everything from muscle contraction to brain activity. That's the link people point to when they call NAD+ an "energy" molecule.

NAD+ does more than power metabolism. It's a required fuel for two families of repair and signaling enzymes:

Sirtuins, which are tied to DNA repair, gene regulation, and many of the pathways studied in aging research.
PARPs, which fix damaged DNA and burn through NAD+ when cells are under stress.

Here's the part that drives the longevity interest: NAD+ levels appear to fall with age in many human tissues. Lower NAD+ has been observed alongside the mitochondrial decline, inflammation, and reduced repair capacity that come with getting older. So the logic goes: levels drop, bad things happen, refill the tank, and maybe some of those problems improve.

That logic is reasonable. It is not proven. A decline in a molecule does not mean replacing it reverses the downstream damage. That gap — between an attractive mechanism and a real outcome — is the whole story of NAD+ therapy right now.

Why "low NAD+" doesn't automatically mean "inject NAD+"

It's worth slowing down on this point, because it's the hinge the entire industry swings on.

Many things decline with age. Some of those declines cause problems. Some are the body's response to other problems. And some are just correlations that go along for the ride. NAD+ falling with age is well documented, but science hasn't fully nailed down whether low NAD+ drives aging, results from it, or both.

The body also guards NAD+ levels tightly. It makes NAD+ through several pathways and recycles it constantly. When you flood the system with extra precursor or infused NAD+, the body often responds by ramping up the enzymes that break NAD+ down and clear it out. That's part of why the lab number can shoot up while the felt effect stays flat. You're not topping off a static tank — you're pushing on a system that pushes back.

None of this means NAD+ therapy can't work. It means the simple story — "levels low, put them back, feel young" — skips over the biology that actually determines whether refilling helps.

How NAD+ Gets Into Your Body

NAD+ is a large, charged molecule. Your gut breaks most of it down before it reaches your bloodstream, which is why oral NAD+ pills are widely considered a poor delivery method. To get meaningful amounts into the body, clinics and patients use a few routes.

NAD+ vs. Its Precursors

A key distinction trips up most readers. There are two different things being sold:

NAD+ itself, given by IV drip or injection.
NAD+ precursors — smaller building blocks the body converts into NAD+. The main ones are NR (nicotinamide riboside), NMN (nicotinamide mononucleotide), and plain niacin/nicotinamide (vitamin B3).

Most of the higher-quality human research is actually on the precursors (especially NR), not on injected NAD+. People often blur these together. They shouldn't, because the evidence is very different for each.

Delivery Routes Compared

Route	How it's given	Bioavailability	Practical notes
Oral NAD+	Capsule/tablet	Very low — degraded in the gut	Cheap but likely ineffective for raising NAD+ directly
Oral precursor (NR/NMN)	Capsule	Moderate; reliably raises blood NAD+	Best-studied route in humans
IV NAD+	Slow drip, often 2–6+ hours	High (direct to bloodstream)	Expensive, time-consuming, common nausea/discomfort during infusion
Subcutaneous NAD+	Injection under the skin	Moderate-to-high; slower "depot" release	Marketed for home use; far less studied
Intramuscular NAD+	Injection into muscle	Moderate	Smaller doses than IV; limited data

One striking finding from a human pharmacokinetic study: during a 6-hour IV NAD+ infusion, plasma NAD+ levels didn't even start rising until roughly 2 hours in, and metabolites showed up in urine — meaning a lot of what's infused is broken down and excreted rather than smoothly taken up by tissues (Grant et al., 2019, PMID 31572171). That detail undercuts the simple "fill the tank instantly" pitch. The body processes NAD+ in complicated ways.

What a typical protocol looks like

Protocols vary widely because none of this is standardized by a regulator. That's a flag in itself. Still, here's the rough landscape you'll encounter at clinics and in home-injection marketing:

IV NAD+ "loading": Several sessions over consecutive days or a couple of weeks, often 250–750 mg or higher per session, each running 2–4+ hours because faster drips cause nausea and chest tightness. Then "maintenance" drips monthly. Costs commonly run several hundred dollars per session.
Subcutaneous NAD+: Smaller doses (often 50–100 mg) injected at home a few times a week, marketed as a cheaper, gentler version of the IV. The "depot" effect means it absorbs slowly from under the skin.
Oral precursors: NR or NMN capsules, typically a few hundred milligrams to ~1,000 mg daily. This is the route with the most human data behind it.

Notice what's missing: agreed-upon dosing, agreed-upon frequency, and outcome trials proving any of these schedules do what they claim. The wide range of "protocols" reflects guesswork dressed up as medicine, not a settled standard of care.

What the Evidence Actually Shows

This is where honesty matters. We'll grade the evidence by claim.

Claim 1: NAD+ therapy raises NAD+ levels — STRONG evidence (for precursors)

This part is solid. Multiple randomized, placebo-controlled human trials show that NAD+ precursors reliably raise blood NAD+ levels in a dose-dependent way.

In a randomized, double-blind trial of healthy overweight adults, NR raised whole-blood NAD+ by roughly 22%, 51%, and 142% at doses of 100, 300, and 1000 mg per day, with the rise sustained over weeks (Conze et al., 2019, PMID 31278280).
A randomized, placebo-controlled study of NR combined with pterostilbene (NRPT) raised blood NAD+ by about 40% at the standard dose and 90% at double dose (Dellinger et al., 2017, PMID 29184669).
In healthy middle-aged and older adults, chronic NR was well tolerated and elevated NAD+ (Martens et al., 2018, PMID 29599478).

So "it raises NAD+" is true and well-documented for oral precursors. Note: most of this evidence is for swallowed NR/NMN, not for injected NAD+. The number on a lab printout going up is the easy part.

A useful way to keep the evidence straight, claim by claim:

Claim	Evidence grade	What the human data show
Raises blood NAD+ (precursors)	Strong	Multiple RCTs; dose-dependent, up to ~142% with 1,000 mg NR
More energy / physical performance	Weak / mixed	Systematic review found non-significant gains for NMN
Better cognition / brain function	Very weak / mixed	One tiny IV pilot positive; larger NR RCT showed no significant benefit
Slows aging / extends lifespan	None (in humans)	No human lifespan or anti-aging trials exist
Helps long-COVID / fatigue syndromes	Weak	NAD+ rose, but primary outcomes not met in RCT

Read top to bottom, the pattern is clear: the evidence is strongest for the thing that matters least to a buyer (a lab value) and weakest for the things people actually pay for (feeling better, living longer).

Claim 2: NAD+ therapy boosts energy and physical performance — WEAK / MIXED evidence

Here the story gets shaky. Raising NAD+ on paper has not clearly translated into the energy and performance gains people expect.

A 2024 systematic review of randomized controlled trials of NMN looked at physical performance across ten studies and about 437 patients. The finding: improvements were non-significant — meaning they could not be distinguished from chance — even though NMN was well tolerated with no serious adverse effects (Nadeeshani et al., 2024, PMID 39221308).

Much of the "I feel amazing" reporting from IV NAD+ clinics is uncontrolled and subjective. No placebo, no blinding, and a several-hundred-dollar price tag that creates a strong expectation effect. That's exactly the setup that produces glowing testimonials regardless of whether the molecule did anything.

Claim 3: NAD+ therapy improves brain function — VERY WEAK / MIXED evidence

A small, often-cited pilot reported that five days of IV NAD+ (750 mg/day) improved scores on 6 of 8 cognitive tests in healthy men. But the study was tiny (about 15 people), unbalanced (only 4 on saline), and not the kind of trial that settles anything.

The most informative recent data cut the other way. A 2025 randomized controlled trial tested high-dose NR in people with long-COVID. NR safely raised NAD+ levels — but it did not produce significant improvements in the trial's main cognition and symptom outcomes versus placebo. Post-hoc analyses hinted that some people who stayed on it for 10+ weeks reported better fatigue and sleep, but those were exploratory, not the rigorous group-versus-placebo comparison (Wu et al., 2025, PMID 41357333).

That trial is a useful reality check. You can raise NAD+ and still see no clear benefit on the outcomes that matter. The molecule moving is not the same as the patient improving.

It's also a reminder of how easily early, small, or uncontrolled studies mislead. The flattering IV cognitive pilot had no real comparison group and a handful of participants. The long-COVID trial was randomized, placebo-controlled, and bigger — and it's the one that found no significant primary benefit. When a stronger study contradicts a weaker one, the stronger study wins. That's not pessimism. It's how evidence is supposed to be weighed.

Claim 4: NAD+ slows aging or extends lifespan in humans — NO evidence

Be blunt about this one. There is no human trial showing NAD+ injections or precursors extend lifespan or reverse aging. The longevity case rests on cell studies, worms, and mice — plus the observation that NAD+ falls with age. Animal results have repeatedly failed to translate to humans across the longevity field. Anyone selling NAD+ as a proven anti-aging treatment is far ahead of the data.

Comparisons and Alternatives

If the goal is simply raising NAD+, the cheapest, best-studied path is an oral precursor — NR or NMN — not an IV. The blood-level evidence above comes mostly from oral dosing. You get the documented biochemical effect without the clinic visit or the needle.

IV and subcutaneous NAD+ itself are far more expensive and far less studied for outcomes. The main argument for injection is bypassing the gut, but as the pharmacokinetic data show, even infused NAD+ is heavily metabolized.

Worth keeping in perspective: the interventions with actual proof for "energy," cognition, and healthy aging are unglamorous. Fixing poor sleep. Treating low iron, low B12, or thyroid problems. Regular exercise — which is itself one of the most reliable ways to support mitochondrial function and may raise NAD+ naturally. A real medical workup for fatigue beats a drip in almost every case, because fatigue often has a fixable cause that NAD+ won't touch.

Ways to support NAD+ without an injection

Some of these have stronger evidence behind the outcome than any NAD+ drip does, even if they don't promise a dramatic lab spike:

Exercise, especially a mix of cardio and resistance training, supports mitochondrial health and is associated with healthier NAD+ metabolism.
Protecting sleep, since the body's NAD+ cycle is tied to daily circadian rhythms.
Avoiding excess alcohol, which taxes NAD+-dependent metabolism.
Eating foods containing B3 and NAD+ precursors — fish, poultry, whole grains, and some dairy — as part of a normal diet.
Oral NR or NMN, if someone wants the documented blood-level effect at low cost and low risk.

The point isn't that these replace a specific therapy. It's that the boring basics carry more proof for actually feeling and aging better than a several-hundred-dollar infusion does.

If you're comparing NAD+ to hormone-based approaches people often weigh against it, our peptides vs. HRT comparison lays out how the two categories differ.

For a broader look at how these compounds are grouped and dosed, see our peptide stacking guide and the complete guide to peptide therapy.

Safety and Side Effects

NAD+ and its precursors have a generally reassuring short-term safety record in trials. The NR and NMN studies above reported good tolerability and no serious adverse events. But "well tolerated in a trial" is not the same as "risk-free for everyone," and a few cautions matter.

Infusion discomfort is common and dose-rate dependent. IV NAD+ frequently causes nausea, chest tightness, flushing, cramping, or a racing sensation if it's run too fast. Slowing the drip usually controls it — which is why infusions take hours.
Injection-site reactions (redness, soreness, swelling) can occur with subcutaneous or intramuscular dosing.
Long-term safety is genuinely unknown. Most human trials run weeks to a few months. There's a theoretical concern, debated among researchers, about whether chronically boosting NAD+ could feed the metabolism of existing cancer cells. This isn't proven harm — it's an open question, and a reason for caution in anyone with a cancer history.
Sourcing risk is real. Compounded and "research-use-only" NAD+ varies in purity and sterility. Injecting a non-sterile or contaminated product is a direct infection and contamination risk.
Drug and condition interactions deserve a check. People on medications, with kidney or liver issues, or with blood pressure problems should clear NAD+ with a physician first, since infusions can transiently affect how you feel and the products aren't standardized.

A note on the testimonials: the strongest-sounding claims for IV NAD+ almost always come from settings with no placebo group, no blinding, and a large fee paid upfront. Those three things together are a recipe for impressive-sounding results that don't hold up under controlled testing. The trials that do control for expectation — the NMN performance review, the long-COVID NR trial — are exactly the ones that came back underwhelming. When you see a dramatic before-and-after story, ask what it's being compared against. Usually the answer is "nothing."

Regulatory Status (U.S., 2026)

This is the part marketing pages skip. Injectable NAD+ is not an FDA-approved drug. It's typically supplied through compounding pharmacies. The FDA evaluates which bulk substances may be used in compounding under Section 503A, and the status of NAD+ has been subject to review and uncertainty rather than clear approval (FDA, Bulk Drug Substances Under Section 503A). Oral NMN's status as a legal dietary supplement has also been contested by the FDA. Translation: you're often buying a product in a gray regulatory zone, not an approved medicine with a proven label.

Who Might Reasonably Consider It

Setting hype aside, here's a sober read.

Reasonable to consider, with eyes open:

People who've already ruled out treatable causes of fatigue (sleep, thyroid, iron, B12, depression) and want to try an oral precursor (NR/NMN), which is low-cost, well-tolerated, and reliably raises NAD+ — while understanding the outcome evidence is weak.
People in supervised clinical settings who understand they're paying for an unproven therapy.

Should be cautious or avoid:

Anyone expecting proven anti-aging or guaranteed energy gains — the data don't support that.
People with a history of cancer, without first discussing it with their oncologist.
Pregnant or breastfeeding people.
Anyone tempted by cheap "research chemical" NAD+ for self-injection — the sourcing and sterility risks are real.

The honest bottom line: NAD+ is a legitimate, important molecule, and you can raise its levels. Whether raising those levels delivers the energy, cognition, and longevity benefits being sold is mostly unproven, and the best recent trial showed higher NAD+ without the hoped-for results. Start with the basics, treat injectable NAD+ as experimental, and let a doctor — not a clinic's sales page — guide the decision.

Frequently Asked Questions

Do NAD+ injections actually give you more energy?

There's no strong proof. NAD+ is central to how cells produce energy, and precursors reliably raise NAD+ levels in the blood. But a 2024 systematic review of NMN trials found only non-significant improvements in physical performance, and much of the "more energy" reporting from IV clinics is uncontrolled and subject to the placebo effect. If you're chronically tired, get evaluated for treatable causes first.

Is injecting NAD+ better than taking it orally?

For raising NAD+ directly, injection bypasses the gut, where oral NAD+ is mostly destroyed — so injection or IV delivers more of the molecule itself. But the best human evidence is actually on swallowed precursors (NR and NMN), which reliably raise blood NAD+ at far lower cost. Injecting plain NAD+ is more expensive and much less studied for real outcomes.

Are NAD+ injections safe?

Short-term, NAD+ and its precursors have a generally good tolerability record in trials, with no serious adverse events reported in the main NR and NMN studies. IV infusions commonly cause nausea, flushing, or chest tightness if run too fast. Long-term safety is unknown, there's an unresolved theoretical concern for people with a cancer history, and self-injecting unregulated product carries infection risk.

Can NAD+ slow down aging or make me live longer?

No human study shows NAD+ injections or precursors extend lifespan or reverse aging. The longevity case comes from cell, worm, and mouse research plus the fact that NAD+ declines with age. Animal longevity findings have a poor track record of translating to humans, so anti-aging claims are well ahead of the evidence.

Is injectable NAD+ FDA-approved?

No. Injectable NAD+ is not an FDA-approved drug. It's usually supplied through compounding pharmacies, and its status as a bulk substance for compounding has been under FDA review rather than approved. You're generally buying a product in a regulatory gray zone, not an approved medicine with a tested label.

This article is for educational purposes only and is not medical advice. NAD+ therapy is largely unproven and not FDA-approved; talk to a qualified healthcare provider before starting any peptide or NAD+ protocol.

Further reading: PubMed search: NAD+ intravenous infusion in humans and PubMed search: NAD+ precursor clinical trials. Related: our 5-Amino-1MQ research review and MOTS-c peptide research review.